I wouldn’t expect Glenmark Pharma to perform better from here on in the back of the out licensing deal, says Prashastha Seth, Senior VP IIFL Private Wealth, IIFL.
first published: May 16, 2011 01:20 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

